Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
Journal of Cellular Biochemistry|March 21, 2007
Dissecting the molecular mechanisms of cancer through bioinformatics-based experimental approachesAshley G Rivenbark, William B Coleman
Expert Opinion on Medical Diagnostics|March 19, 2013
pRb2/p130: a gene target for diagnosis and treatment of cancerWilliam B Coleman, Ashley G Rivenbark
Experimental and Molecular Pathology|November 13, 2012
Field cancerization in mammary carcinogenesis - Implications for prevention and treatment of breast cancerAshley G Rivenbark, William B Coleman
Frontiers in Bioscience (Landmark Edition)|March 11, 2009
Epigenetic regulation of cystatins in cancerAshley G Rivenbark, William B Coleman
Expert Opinion on Medical Diagnostics|March 16, 2013
Practical applications for epigenetic biomarkers in cancer diagnosticsAshley G Rivenbark, William B Coleman
Laboratory Investigation; a Journal of Technical Methods and Pathology|October 18, 2006
DNA methylation-dependent silencing of CST6 in human breast cancer cell linesAshley G Rivenbark, Wendell D Jones, William B Coleman
Breast Cancer Research and Treatment|March 2, 2011
Enhancement of chemotherapeutic efficacy in hypermethylator breast cancer cells through targeted and pharmacologic inhibition of DNMT3bRupninder Sandhu, Ashley G Rivenbark, William B Coleman
International Journal of Oncology|June 6, 2012
Loss of post-transcriptional regulation of DNMT3b by microRNAs: a possible molecular mechanism for the hypermethylation defect observed in a subset of breast cancer cell linesRupninder Sandhu, Ashley G Rivenbark, William B Coleman
The American Journal of Pathology|September 3, 2013
Molecular and cellular heterogeneity in breast cancer: challenges for personalized medicineAshley G Rivenbark, Siobhan M O'Connor, William B Coleman
The American Journal of Pathology|December 27, 2014
Dysregulation of the epigenome in human breast cancer: contributions of gene-specific DNA hypermethylation to breast cancer pathobiology and targeting the breast cancer methylome for improved therapyRupninder Sandhu, J Devon Roll, Ashley G Rivenbark, et al.
Pageof 2